- Hyponatremia with Neurological Symptom in Patients with Chronic Schizophrenia : Five Cases
-
Cho GH, Chung YC, Lim ES
- KMID: 1512823
- Korean J Psychopharmacol.
- 2007 Mar;18(2):110-117.
Hyponatremia frequently occurs in patients with chronic schizophrenia and has various causes such as compulsive drinking, neuroleptics, and physical illness. If not corrected immediately, it leads to severe problems such... -
- CITED
-
- Close
- SHARE
-
- Close
- Two-Year Rehospitalization Rates of First Episode Schizophrenic Inpatients Discharged on Antipsychotic Medication : A Preliminary Study
-
Woo YS, Yook DH, Seo HJ, Chae JH, Jun TY, Bahk WM
- KMID: 1512820
- Korean J Psychopharmacol.
- 2007 Mar;18(2):86-91.
OBJECTIVE: We compared the rehospitalization rate of first-episode schizophrenic inpatients who were discharged from a university hospital while being treated with risperidone, olanzapine, quetiapine, or the conventional antipsychotic haloperidol. We... -
- CITED
-
- Close
- SHARE
-
- Close
- Body Mass Index(BMI) Changes during Combination Therapy with Mood Stabilizers and Antipsychotics in Acute Mania
-
Jun JS, Kim JY, Shin YB, Kim CE, Lee JS, Bae JN, Kang MH
- KMID: 1512822
- Korean J Psychopharmacol.
- 2007 Mar;18(2):103-109.
OBJECTIVE: To estimate changes in body mass index (BMI) during the treatment of acute manic patients, we retrospectively analyzed the medical records of patients admitted to Inha University Medical Center... -
- CITED
-
- Close
- SHARE
-
- Close
- Assessment of Abdominal Fat and Mid-Thigh Low-Density Muscle Areas in Patients with Schizophrenia
-
Kim CS, Nam YY, Park JS, Kim HJ, Noh TW, Nam JS, Ahn CW, Kim KR, Cha KR, Kim CH
- KMID: 1512819
- Korean J Psychopharmacol.
- 2007 Mar;18(2):81-85.
OBJECTIVE: Patients with schizophrenia are at a higher risk for developing insulin resistance and type 2 diabetes mellitus (T2DM). However, few studies have examined abdominal fat and mid-thigh low-density muscle... -
- CITED
-
- Close
- SHARE
-
- Close
- Body Weight Gain and Metabolic Changes in Patients with Schizophrenia during 12-Week Randomized Treatment of Ziprasidone and Risperidone
-
Ahn YM, Lee KY, Kim KS, Kim DK, Kim YH, Kim CY, Kim CE, Min S, Park MC, Shin YM, Cho HS, Kim YS
- KMID: 1512821
- Korean J Psychopharmacol.
- 2007 Mar;18(2):92-102.
OBJECTIVE: Body weight gain and metabolic syndrome are frequent adverse side effects of atypical antipsychotics. However, ziprasidone has been reported to have less effect on body weight and other metabolic... -
- CITED
-
- Close
- SHARE
-
- Close
